March 18, 2022 -- Oakdale, MI-based InSitu Biologics has been welcomed into in5, one of the United Arab Emirates' leading incubators, which specializes in supporting tech, media, and design startups.
The company said that the partnership will allow InSitu Biologics to advance its ability to conduct investigational and clinical studies internationally, secure funding, and build important partnerships in the region.
InSitu will also be presenting as in5's first health partner company in the upcoming Advance Health event "Future of Biotech R&D in UAE." The company participated in the Arab Health 2022 conference in January.
More information about in5 can be found on its site.